ATC code L01#L01A Alkylating agents
{{Short description|Pharmaceutical drug classification}}
{{ATC codes lead|L|01|Antineoplastic agents|vet=add}}
{{anchor|L01A}}L01A Alkylating agents
={{anchor|L01AA}}L01AA Nitrogen mustard analogues=
:L01AA01 Cyclophosphamide
:L01AA02 Chlorambucil
:L01AA03 Melphalan
:L01AA05 Chlormethine
:L01AA06 Ifosfamide
:L01AA07 Trofosfamide
:L01AA08 Prednimustine
:L01AA09 Bendamustine
:L01AA10 Melphalan flufenamide
={{anchor|L01AB}}L01AB Alkyl sulfonates=
={{anchor|L01AC}}L01AC Ethylene imines=
={{anchor|L01AD}}L01AD Nitrosoureas=
:L01AD01 Carmustine
:L01AD02 Lomustine
:L01AD03 Semustine
:L01AD04 Streptozocin
:L01AD05 Fotemustine
:L01AD06 Nimustine
:L01AD07 Ranimustine
:L01AD08 Uramustine
={{anchor|L01AG}}L01AG Epoxides=
:L01AG01 Etoglucid
={{anchor|L01AX}}L01AX Other alkylating agents=
{{anchor|L01B}}L01B Antimetabolites
={{anchor|L01BA}}L01BA Folic acid analogues=
={{anchor|L01BB}}L01BB Purine analogues=
:L01BB02 Mercaptopurine
:L01BB03 Tioguanine
:L01BB04 Cladribine
:L01BB05 Fludarabine
:L01BB06 Clofarabine
:L01BB07 Nelarabine
:QL01BB90 Rabacfosadine
={{anchor|L01BC}}L01BC Pyrimidine analogues=
:L01BC01 Cytarabine
:L01BC02 Fluorouracil
:L01BC03 Tegafur
:L01BC04 Carmofur
:L01BC05 Gemcitabine
:L01BC06 Capecitabine
:L01BC07 Azacitidine
:L01BC08 Decitabine
:L01BC09 Floxuridine
:L01BC52 Fluorouracil, combinations
:L01BC53 Tegafur, combinations
:L01BC58 Decitabine, combinations
:L01BC59 Trifluridine, combinations
{{anchor|L01C}}L01C Plant alkaloids and other natural products
={{anchor|L01CA}}L01CA Vinca alkaloids and analogues=
:L01CA01 Vinblastine
:L01CA02 Vincristine
:L01CA03 Vindesine
:L01CA04 Vinorelbine
:L01CA05 Vinflunine
:L01CA06 Vintafolide
={{anchor|L01CB}}L01CB Podophyllotoxin derivatives=
:L01CB01 Etoposide
:L01CB02 Teniposide
={{anchor|L01CC}}L01CC Colchicine derivatives=
:L01CC01 Demecolcine
={{anchor|L01CD}}L01CD Taxanes=
:L01CD01 Paclitaxel
:L01CD02 Docetaxel
:L01CD03 Paclitaxel poliglumex
:L01CD04 Cabazitaxel
:L01CD51 Paclitaxel and encequidar
={{anchor|L01CE}}L01CE Topoisomerase 1 (TOP1) inhibitors=
={{anchor|L01CX}}L01CX Other plant alkaloids and natural products=
:L01CX01 Trabectedin
={{anchor|L01DA}}L01DA Actinomycines=
:L01DA01 Dactinomycin
={{anchor|L01DC}}L01DC Other cytotoxic antibiotics=
{{anchor|L01E}}L01E Protein kinase inhibitors
={{anchor|L01EA}}L01EA BCR-ABL tyrosine kinase inhibitors=
={{anchor|L01EB}}L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors=
:L01EB01 Gefitinib
:L01EB02 Erlotinib
:L01EB03 Afatinib
:L01EB04 Osimertinib
:L01EB05 Rociletinib
:L01EB06 Olmutinib
:L01EB07 Dacomitinib
:L01EB08 Icotinib
:L01EB09 Lazertinib
:L01EB10 Mobocertinib
:L01EB11 Aumolertinib
={{anchor|L01EC}}L01EC B-Raf serine-threonine kinase (BRAF) inhibitors=
={{anchor|L01ED}}L01ED Anaplastic lymphoma kinase (ALK) inhibitors=
={{anchor|L01EE}}L01EE Mitogen-activated protein kinase (MEK) inhibitors=
:L01EE01 Trametinib
:L01EE02 Cobimetinib
:L01EE03 Binimetinib
:L01EE04 Selumetinib
:L01EE05 Mirdametinib
={{anchor|L01EF}}L01EF Cyclin-dependent kinase (CDK) inhibitors=
={{anchor|L01EG}}L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors=
={{anchor|L01EH}}L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors=
={{anchor|L01EJ}}L01EJ Janus-associated kinase (JAK) inhibitors=
={{anchor|L01EK}}L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors=
={{anchor|L01EL}}L01EL Bruton's tyrosine kinase (BTK) inhibitors=
:L01EL01 Ibrutinib
:L01EL02 Acalabrutinib
:L01EL03 Zanubrutinib
:L01EL04 Orelabrutinib
:L01EL05 Pirtobrutinib
:L01EL06 Tirabrutinib
={{anchor|L01EM}}L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors=
={{anchor|L01EN}}L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors=
={{anchor|L01EX}}L01EX Other protein kinase inhibitors=
:L01EX01 Sunitinib
:L01EX02 Sorafenib
:L01EX03 Pazopanib
:L01EX04 Vandetanib
:L01EX05 Regorafenib
:L01EX06 Masitinib
:L01EX07 Cabozantinib
:L01EX08 Lenvatinib
:L01EX09 Nintedanib
:L01EX10 Midostaurin
:L01EX11 Quizartinib
:L01EX12 Larotrectinib
:L01EX13 Gilteritinib
:L01EX14 Entrectinib
:L01EX15 Pexidartinib
:L01EX17 Capmatinib
:L01EX18 Avapritinib
:L01EX19 Ripretinib
:L01EX21 Tepotinib
:L01EX22 Selpercatinib
:L01EX23 Pralsetinib
:L01EX24 Surufatinib
:L01EX25 Umbralisib
:L01EX26 Sitravatinib
:L01EX27 Capivasertib
:L01EX28 Repotrectinib
:QL01EX90 Toceranib
{{anchor|L01F}}L01F Monoclonal antibodies and antibody drug conjugates
={{anchor|L01FA}}L01FA CD20 (clusters of differentiation 20) inhibitors=
={{anchor|L01FB}}L01FB CD22 (clusters of differentiation 22) inhibitors=
:L01FB01 Inotuzumab ozogamicin
:L01FB02 Moxetumomab pasudotox
={{anchor|L01FC}}L01FC CD38 (clusters of differentiation 38) inhibitors=
:L01FC01 Daratumumab
:L01FC02 Isatuximab
={{anchor|L01FD}}L01FD HER2 (human epidermal growth factor receptor 2) inhibitors=
:L01FD01 Trastuzumab
:L01FD02 Pertuzumab
:L01FD03 Trastuzumab emtansine
:L01FD04 Trastuzumab deruxtecan
:L01FD05 Trastuzumab duocarmazine
:L01FD06 Margetuximab
:L01FD07 Zanidatamab
={{anchor|L01FE}}L01FE EGFR (epidermal growth factor receptor) inhibitors=
={{anchor|L01FF}}L01FF PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors=
:L01FF01 Nivolumab
:L01FF02 Pembrolizumab
:L01FF03 Durvalumab
:L01FF04 Avelumab
:L01FF05 Atezolizumab
:L01FF06 Cemiplimab
:L01FF07 Dostarlimab
:L01FF08 Prolgolimab
:L01FF09 Tislelizumab
:L01FF10 Retifanlimab
:L01FF11 Sugemalimab
:L01FF12 Serplulimab
:L01FF13 Toripalimab
={{anchor|L01FG}}L01FG VEGF/VEGFR (vascular endothelial growth factor) inhibitors=
:L01FG01 Bevacizumab
:L01FG02 Ramucirumab
={{anchor|L01FX}}L01FX Other monoclonal antibodies and antibody drug conjugates=
:L01FX01 Edrecolomab
:L01FX02 Gemtuzumab ozogamicin
:L01FX03 Catumaxomab
:L01FX04 Ipilimumab
:L01FX05 Brentuximab vedotin
:L01FX06 Dinutuximab beta
:L01FX07 Blinatumomab
:L01FX08 Elotuzumab
:L01FX09 Mogamulizumab
:L01FX10 Olaratumab
:L01FX11 Bermekimab
:L01FX12 Tafasitamab
:L01FX13 Enfortumab vedotin
:L01FX14 Polatuzumab vedotin
:L01FX15 Belantamab mafodotin
:L01FX16 Oportuzumab monatox
:L01FX17 Sacituzumab govitecan
:L01FX18 Amivantamab
:L01FX19 Sabatolimab
:L01FX20 Tremelimumab
:L01FX21 Naxitamab
:L01FX22 Loncastuximab tesirine
:L01FX23 Tisotumab vedotin
:L01FX24 Teclistamab
:L01FX25 Mosunetuzumab
:L01FX26 Mirvetuximab soravtansine
:L01FX27 Epcoritamab
:L01FX28 Glofitamab
:L01FX29 Talquetamab
:L01FX31 Zolbetuximab
:L01FX32 Elranatamab
:L01FX33 Tarlatamab
:L01FX34 Odronextamab
:L01FX35 Datopotamab deruxtecan
:L01FX36 Patritumab deruxtecan
={{anchor|L01FY}}L01FY Combinations of monoclonal antibodies and antibody drug conjugates=
:L01FY01 Pertuzumab and trastuzumab
:L01FY02 Nivolumab and relatlimab
:L01FY03 Prolgolimab and nurulimab
{{anchor|L01X}}L01X Other antineoplastic agents
={{anchor|L01XA}}L01XA Platinum compounds=
:L01XA01 Cisplatin
:L01XA02 Carboplatin
:L01XA03 Oxaliplatin
:L01XA04 Satraplatin
:L01XA05 Polyplatillen
={{anchor|L01XB}}L01XB Methylhydrazines=
:L01XB01 Procarbazine
={{anchor|L01XD}}L01XD Sensitizers used in photodynamic/radiation therapy=
:L01XD01 Porfimer sodium
:L01XD03 Methyl aminolevulinate
:L01XD04 Aminolevulinic acid
:L01XD05 Temoporfin
:L01XD06 Efaproxiral
:L01XD07 Padeliporfin
={{anchor|L01XF}}L01XF Retinoids for cancer treatment=
={{anchor|L01XG}}L01XG Proteasome inhibitors=
={{anchor|L01XH}}L01XH Histone deacetylase (HDAC) inhibitors=
:L01XH01 Vorinostat
:L01XH02 Romidepsin
:L01XH03 Panobinostat
:L01XH04 Belinostat
:L01XH05 Entinostat
:L01XH06 Tucidinostat
:L01XH07 Resminostat
={{anchor|L01XJ}}L01XJ Hedgehog pathway inhibitors=
={{anchor|L01XK}}L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors =
:L01XK01 Olaparib
:L01XK02 Niraparib
:L01XK03 Rucaparib
:L01XK04 Talazoparib
:L01XK05 Veliparib
:L01XK06 Pamiparib
:L01XK52 Niraparib and abiraterone
={{anchor|L01XL}}L01XL Antineoplastic cell and gene therapy =
:L01XL01 Sitimagene ceradenovec
:L01XL02 Talimogene laherparepvec
:L01XL03 Axicabtagene ciloleucel
:L01XL04 Tisagenlecleucel
:L01XL05 Ciltacabtagene autoleucel
:L01XL06 Brexucabtagene autoleucel
:L01XL07 Idecabtagene vicleucel
:L01XL08 Lisocabtagene maraleucel
:L01XL09 Tabelecleucel
:L01XL10 Nadofaragene firadenovec
:L01XL11 Lifileucel
:L01XL12 Obecabtagene autoleucel
={{anchor|L01XM}}L01XM Isocitrate dehydrogenase (IDH) inhibitors=
={{anchor|L01XU}}L01XU Other antineoplastic agents (cont.)=
:Empty group
={{anchor|L01XX}}L01XX Other antineoplastic agents=
:L01XX01 Amsacrine
:L01XX02 Asparaginase
:L01XX03 Altretamine
:L01XX05 Hydroxycarbamide
:L01XX07 Lonidamine
:L01XX08 Pentostatin
:L01XX10 Masoprocol
:L01XX11 Estramustine
:L01XX16 Mitoguazone
:L01XX18 Tiazofurine
:L01XX23 Mitotane
:L01XX24 Pegaspargase
:L01XX27 Arsenic trioxide
:L01XX29 Denileukin diftitox
:L01XX33 Celecoxib
:L01XX35 Anagrelide
:L01XX36 Oblimersen
:L01XX40 Omacetaxine mepesuccinate
:L01XX41 Eribulin
:L01XX44 Aflibercept
:L01XX46 Olaparib
:L01XX52 Venetoclax
:L01XX53 Vosaroxin
:L01XX57 Plitidepsin
:L01XX58 Epacadostat
:L01XX66 Selinexor
:L01XX67 Tagraxofusp
:L01XX69 Lurbinectedin
:L01XX72 Tazemetostat
:L01XX73 Sotorasib
:L01XX74 Belzutifan
:L01XX75 Tebentafusp
:L01XX77 Adagrasib
:L01XX78 Navitoclax
:L01XX79 Eflornithine
:L01XX80 Imetelstat
:L01XX81 Nirogacestat
:L01XX82 Darinaparsin
:L01XX83 Para-toluenesulfonamide
:L01XX84 Pelabresib
:L01XX85 Idroxioleic acid
:L01XX86 Calaspargase pegol
:QL01XX91 Tigilanol tiglate
:QL01XX92 Verdinexor
={{anchor|L01XY}}L01XY Combinations of antineoplastic agents=
:L01XY01 Cytarabine and daunorubicin
:L01XY04 Bifikafusp alfa and onfekafusp alfa